Eiko Lifesciences standalone net profit declines 57.14% in the March 2022 quarter

Sales decline 13.84% to Rs 5.29 crore

Net profit of Eiko Lifesciences declined 57.14% to Rs 0.15 crore in the quarter ended March 2022 as against Rs 0.35 crore during the previous quarter ended March 2021. Sales declined 13.84% to Rs 5.29 crore in the quarter ended March 2022 as against Rs 6.14 crore during the previous quarter ended March 2021.

For the full year,net profit rose 16.39% to Rs 0.71 crore in the year ended March 2022 as against Rs 0.61 crore during the previous year ended March 2021. Sales rose 111.93% to Rs 25.41 crore in the year ended March 2022 as against Rs 11.99 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales5.296.14 -14 25.4111.99 112 OPM %4.916.84 -5.084.34 - PBDT0.360.50 -28 1.500.89 69 PBT0.200.48 -58 0.940.83 13 NP0.150.35 -57 0.710.61 16

Powered by Capital Market - Live News